Presence of Cx43 in extracellular vesicles reduces the cardiotoxicity of the anti-tumour therapeutic approach with doxorubicin.

J Extracell Vesicles · 2016 · PMC5045474 · PMID 27702427

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Although the presence of Cx43 in EVs did not show a statistically significant difference in terms of therapeutic effect of dox, in the majority of the evaluated parameters there is a clear trend for EV Cx43+ to present a better anti-tumoural performance, compared to EV Cx43− .

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.